Clostridium Difficile Infections Clinical Trial
Official title:
Virus as Treatment of C. Difficile Infection (VISION)
Fecal Virome Transplantation (FVT) has in small studies shown benefit in the treatment of recurrent C. difficile infection. In the VISION study we will treat patients with recurrent C. difficile infection with FVT capsules and compare the treatment with Fecal Microbiota Transplantation (FMT) capsules. Both will be following af standard treatment of antibiotics (Vancomycin)
In the VISION study we will treat patients with recurrent C. difficile infection (CDI) with FVT capsules and compare the treatment with Fecal Microbiota Transplantation (FMT) capsules. Patients will be randomised to receive either FMT or FTV capsules. Patients will be followed for one year to investigate the risk of a new recurrence of CDI. Patients and researchers involved in the treatment of the patients will be blinded to the treatment ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030245 -
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance
|
||
Completed |
NCT01957761 -
Molecular Epidemiology of Clostridium Difficile Infections in Children
|
N/A | |
Recruiting |
NCT05714566 -
Research on Gut Microbiome and Metabolomics Alterations in C.Difficile Infected IBD Patients
|
||
Recruiting |
NCT06237452 -
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
|
Phase 3 | |
Not yet recruiting |
NCT06107569 -
Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma
|
Phase 3 | |
Not yet recruiting |
NCT05256693 -
Prevention of C.Difficile Infections With Oral Vancomycine in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
|
Phase 3 | |
Recruiting |
NCT06311006 -
Safety Registry of a Fecal Microbiota Transplant Cohort
|
||
Recruiting |
NCT05430269 -
Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients
|
N/A |